Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:21 PM
Ignite Modification Date:
2025-12-24 @ 9:21 PM
NCT ID:
NCT01669304
Eligibility Criteria:
Inclusion criteria:
1. Neurotologic diagnoses of both vestibular migraine and chronic subjective dizziness
2. All other co-existing medical or psychiatric conditions are stable, and no greater than moderate severity
3. Able to complete study assessments in person and by phone
4. Able to travel to Mayo Clinic, Rochester, Minnesota for first and last study visits
5. Willing to avoid pregnancy during study (abstinence or acceptable birth control)
Exclusion criteria:
1. Presence of any other active neurotologic diagnoses
2. Medical or psychiatric conditions that would preclude or confound study drugs
3. Use of medications or supplements that would preclude or confound study drugs
4. Past treatment of headache or dizziness with a full trial of a calcium channel blocker or selective serotonin reuptake inhibitor
5. Allergy to verapamil or sertraline
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01669304
Study Brief:
Protocol Section:
NCT01669304